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PRINCIPLES: The efficacy of low-calorie diets (LCDs)
has not been investigated in large-scale studies or among
people from different regions, who are perhaps unaccus-
tomed to such methods of losing weight. The aim of the
present study was to investigate changes in obesity meas-
ures among overweight/obese adults from eight European
cities (from Northern, Central and Southern Europe) during
the 8-week LCD phase of the DiOGenes study
(2006–2007), a family-based, randomised, controlled diet-
ary intervention.
METHODS: 938 overweight/obese adults completed
baseline examinations and underwent an 8-week LCD,
providing 3.3–4.2 MJ/day to replace all meals. Anthropo-
metric measurements and body composition were assessed
at baseline and post-LCD.
RESULTS: 773 (82.4%) adults (mean age, 43.1 y) com-
pleted the LCD successfully. The highest drop-out rate was
observed in Southern (24.9%) and the lowest in Northern
(13.3%) European cities. Overall, the LCD induced favour-
able changes in all outcomes, including an approximate
11.0% reduction in body weight and body fat percentage.
Changes in outcomes differed significantly between re-
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gions, with North- and Central-European cities generally
achieving higher percentage reductions in most anthropo-
metric measurements assessed. Nonetheless, participants in
Southern Europe reduced their body fat percentage signi-
ficantly more than participants in Northern Europe (–11.8
vs. –9.5%, P = 0.017).
CONCLUSIONS: The LCD significantly improved anthro-
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Introduction
Obesity has, in recent years, evolved into a worldwide epi-
demic [1]. Despite the investigation of meal patterns with
varying macronutrient composition, it seems that the most
effective diet leading to successful weight loss and main-
tenance has yet to be established [2]. Low-calorie diets
(LCDs), in the form of energy-controlled, micronutrient-
fortified liquid meals consumed as meal replacements,
have often been prescribed for obese subjects or when rapid
weight loss is a medical necessity [3]. Although not inten-
ded to act as a substitute for lifestyle modifications, LCDs
appear popular, as they generally result in greater weight
loss [4] and long-term weight maintenance [5, 6], com-
pared to conventional diets. The success of LCDs is at-
tributed to the production of greater satiety than alternative
foods of equal or greater energy content [7]. LCDs, espe-
cially when combined with behavioural therapy and active
follow-up with nutritional education and physical activity,
are likely to lead to a larger long-term weight maintenance
[5, 8–12], probably the result of the greater initial weight
loss induced by such diets [9].
The efficacy of LCDs has not been investigated in large-
scale studies or among people from different regions.
DiOGenes (Diet, Obesity and Genes) is an integrated,
family-based, randomised controlled dietary intervention
study performed in eight European cities, examining di-
etary means of preventing weight regain after an initial
8-week run-in LCD weight-loss period [13–16]. To date,
the majority of published research on LCDs has been un-
dertaken in North America and North or Central European
countries [17], including countries participating in
DiOGenes (i.e., the Netherlands [18, 19], Denmark [20,
21], UK [22, 23], Germany [24], the Czech Republic [25,
26] and Spain [27, 28]. The aim of the current paper was
to investigate the degree of weight loss, as well as changes
in anthropometric and body composition measurements,
among overweight/obese adults from eight European cities
(from Northern, Central and Southern Europe) during the
8-week LCD phase of the DiOGenes study.
Materials and methods
Participants
Volunteer families were recruited from eight cities across
eight European countries: Maastricht (the Netherlands),
Copenhagen (Denmark), Cambridge (United Kingdom),
Heraklion (Greece), Potsdam (Germany), Pamplona
(Spain), Sofia (Bulgaria) and Prague (Czech Republic).
Recruitment commenced in March 2006 and was com-
pleted in April 2007. Families attended a screening exam-
ination to determine eligibility. Participating adults had to
be healthy, overweight/ obese (27≤ body mass index (BMI,
kg/m2) <45) and aged <65 y. A detailed description of re-
cruitment strategies, adult exclusion criteria and screening
examinations is provided elsewhere [14]. Informed consent
was obtained from all participants and the study was ap-
proved by the local Medical Ethical Committees in the re-
spective research centers, in accordance with the Helsinki
Declaration.
Study design and procedures
Eligible adults underwent a clinical examination (repres-
enting ‘baseline’) following their screening, when anthro-
pometric measures and body composition were assessed.
Subsequently participants entered an 8-week LCD period,
with the aim of obtaining a minimum weight loss of 8%. A
large weight loss in a short time period was chosen, to mo-
tivate participants to adhere to the main phase of the study
[14] and to select the participants who were likely to show
compliance during the randomised phase of the DiOGenes
intervention [14]. Participants met the research dieticians
approximately every two weeks (a total of approximately
6 visits) during the LCD period for weighing, compliance
assessment and dietary instructions. Participants who re-
ported difficulties with adhering to or non-compliance to
the LCD were excluded from the study. At the end of the
8-week LCD period, those participants who achieved the
target weight loss underwent a second clinical examina-
tion (representing ‘post-LCD’) and were subsequently ran-
domised to one of five energy ad libitum diets for 6–12
months [13, 14, 29]. The present paper reports on these
participants. In exceptional circumstances, e.g. when par-
ticipants were unavailable to attend the post-LCD exam-
ination at exactly 8 weeks, less or more time on the LCD
was allowed, provided the diet’s duration was between 7–9
weeks.
LCD intervention
The energy-restricted LCD (MODIFAST®, Nutrition et
Santé, France) consisted of 3.3 MJ/d (800 kcal/d), with
a macronutrient composition of 15–20% of total energy
from fat, 35–40% from protein and 45–50% from carbo-
hydrates. The MODIFAST® products were available in 55
g sachets and included a range of products in a variety of
flavours, namely powder drinks, crèmes and soups. Parti-
cipants were required to consume a total of four sachets
daily, eaten at intervals distributed across the day to replace
breakfast, lunch, dinner and one snack-meal. This provided
them with a daily intake of 54 g protein, ~5 g essential fatty
acids and the daily requirement for vitamins and minerals.
In exceptional cases, when lack of satiety was reported, a
fifth sachet could be consumed.
Participants were free to add spices, herbs and low-calorie/
calorie-free flavourings (i.e., calorie-free juice, coffee or
instant coffee) to increase variety and taste of the products.
In addition to the four sachets, participants were also per-
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mitted without limitation to: drink coffee and tea (if neces-
sary adding a little skimmed milk); drink sufficient quantit-
ies of water; drink calorie-free soft drinks; and chew sugar-
free chewing gum/pastilles. Further, it was permitted to eat
200 g tomatoes, 125 g cucumber and 50 g lettuce on a daily
basis. Thus, participants were provided with 3.3–4.2 MJ/d
(800–1000 kcal/d).
Anthropometric measurements and body composition
Standard operation procedures were produced for all in-
vestigations undertaken to ensure standardisation across
the cities and the same measurement devices and methods
were used in each research centre on every occasion a
measurement was provided [14]. Subjects had been fasting
for twelve hours before the clinical examinations in the
early morning and they were measured in their underwear,
with an empty bladder.
Weight was measured on calibrated digital scales to the
nearest 0.1 kg on all examinations and dietary counselling
sessions, and height was measured at baseline, to the
nearest mm with a wall-mounted stadiometer. BMI was
calculated as weight divided by height squared (kg/m2).
Waist circumference (WC), measured midway between the
lower rib and iliac crest) and hip circumference (HC),
measured at the widest point between the hips and but-
tocks) were measured twice, to the nearest 0.5cm, with a
tape in a vertical plane and with the subject standing and
gently breathing out. Waist-to-hip ratio was then calcu-
lated. Sagittal abdominal diameter was measured using an
abdominal caliper to the nearest mm, at the highest point of
the abdomen during expiration, with subjects supine [14].
Fat mass (kg), body fat percentage and fat-free mass (kg,
defined as the sum of lean body mass and bone mineral
content) were determined by dual-energy X-ray absorption
(DXA) or by bioelectric impedance analysis (BIA). Adults
who participated in the determination of body composition
were fasting (no intake of foods or liquids for at least 4
hours prior to the examinations, except for a water intake
of 350–500 mL).
Statistical analyses
All analyses were performed using the Statistical Package
for the Social Sciences (IBM SPSS for Windows, release
19, 2010, SPSS, Chicago, Illinois). Drop-out from the
study during the 8-week LCD phase (non-completers) was
determined by assessing the number of participants who
entered the LCD phase and the number who successfully
completed the LCD and were randomised to the main
DiOGenes intervention (completers). For both LCD com-
pleters and non-completers the distribution of participants
according to gender was compared between the different
cities using the Pearson’s chi-square test. Differences in
gender distribution and age between completers and non-
completers were assessed using Pearson’s chi-square test
and analysis of variance respectively. Age of participants
and LCD duration (in weeks) were compared between the
cities using the Kruskal Wallis rank test. Comparisons of
overall changes in anthropometric measurements and body
composition during the LCD period between Northern
(Maastricht, Copenhagen, Cambridge), Central (Prague,
Potsdam) and Southern (Heraklion, Pamplona, Sofia)
European regions were performed using analysis of covari-
ance, with age, gender and LCD duration as covariates and
pair-wise comparisons, with age, gender, baseline body fat
percentage and LCD duration as covariates.
Results
A total of 1 209 adults were registered to attend screening
and 938 (77.6%) attended the baseline examination and
entered the LCD period. Of these, 773 (82.4%) adults (273
males, 500 females, mean age, 43.1 y) successfully com-
pleted the LCD and were included in the present analyses.
Overall, 165 adults (17.6% of those who entered the LCD)
dropped out or were excluded during the LCD. The dis-
tribution of participants across different cities and regions
is shown in figure 1. The highest drop-out was observed
in Heraklion, Pamplona and Cambridge, and the lowest in
Copenhagen. The combined analyses of cities according to
region showed that mean drop-out was higher in South-
ern (24.9%) than in Central (16.2%) or Northern European
(13.3%) cities (fig. 1). Among non-completers of the LCD
Figure 1
Flow diagram showing progress of the DiOGenes participants from
screening to post-LCD, 2006–2007.
Figure 2
Body fat percentage over the LCD period in the DiOGenes
participating regions, 2006–2007.
LCD = low-calorie diet; bars (I) indicate 95% confidence intervals;
comparisons in body fat percentage changes between regions were
performed using analysis of covariance, with age, gender, baseline
body fat percentage and LCD duration (weeks) as covariates.
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period, there was no difference between the cities in the
distribution of genders (P = 0.869, data not shown). Non-
completers were younger (41.2 vs. 43.1y, P <0.001) than
LCD completers.
Among cities, gender distribution differed significantly (P
= 0.033). Participants in Heraklion were significantly
younger (P <0.001) and followed the LCD for a longer
period (P <0.001), compared to other cities (table 1).
The mean and percental changes in anthropometric and
body composition measurements during the LCD period in
the three different European regions and the total sample
are shown in table 2. Overall, the LCD induced favuorable
changes in all measured outcomes and an 11.1% (11.1 kg)
and 11.0% reduction in body weight and fat percentage,
respectively. Changes in all outcomes, except body weight
and BMI, differed significantly between the regions. In
general, participants in the Northern and Central European
regions achieved higher reductions in most anthropometric
measurements assessed, compared to the Southern
European region (table 2). However, participants from the
Southern European cities reduced their fat mass
significantly more (–21.5%, P <0.01) and their fat-free
mass significantly less (–3.6%, P <0.01), compared to
participants from the Northern (–19.3% and -5.7%,
respectively) and Central (–19.6% and –5.7%,
respectively) European regions. Body fat percentage
changes during the LCD period tended to differ between
the groups of cities (P = 0.054) (fig. 2). Pair-wise
comparisons revealed that participants in the Southern
region reduced their body fat significantly more than
participants in the Northern European region (P = 0.017)
(fig. 2).
Discussion
LCDs have frequently been scientificall evaluated in the
last decades, as they result in rapid weight loss, which
renders this method popular among obese subjects who
consider it acceptable [6, 30] and are likely to help achieve
long-term weight loss maintenance [6, 9, 24], compared to
conventional diets. In the present study, overweight/obese
adult volunteers from 8 European cities participating in the
DiOGenes study followed an LCD for a mean of 8.2 weeks
and lost an average of 11.1% body weight. Such a reduc-
tion in body weight has been associated with significant
improvements in obesity-related disorders and complica-
tions [11, 24]. In addition, the LCD produced favorable
changes in a variety of anthropometric and body compos-
ition measurements across different European regions, in-
dicating its efficacy in a large-scale study where a large
weight loss in a short time period was required.
Participants in the present study lost an average of 2.8 kg
(4.7%) of fat-free mass, corresponding to 25.2% of the
weight lost, which is comparable to earlier research and
considered acceptable in weight loss efforts [18, 31–34].
Although earlier studies have been inconsistent with regard
to the role of initial BMI and body composition in the loss
of fat-free mass and body weight respectively [18, 33], we
accounted for any potential effect of baseline values by
examining absolute and percentage changes in these para-
meters. Nevertheless, weight reduction in the present study
was mainly attributed to reduction in body fat. It should
be noted however, that comparisons with earlier studies are
hindered, due to differences in diet type and energy con-
tent (LCD vs. very-low-calorie diets), LCD definition and
duration and baseline characteristics of participants, such
as initial BMI. DiOGenes is, to the best of our knowledge,
the first study to provide an opportunity for a comparison
of LCD efficacy between different European regions. All
eight research centres successfully implemented the LCD,
although changes in the majority of outcome measures
differed significantly between regions, despite standardisa-
tion of protocols and procedures. In general, participants in
the Northern and Central European regions achieved high-
er percentage reductions in most anthropometric measure-
ments assessed, compared to participants from Southern
Europe. Nonetheless, participants in the Southern
European region generally achieved significantly higher re-
ductions in body fat percentage.
Drop-out in the present study was slightly higher than with-
drawal rates reported in some earlier studies [35, 36], but
lower compared to the only other multi-centre study we
could identify, which comprised a national intervention in
the USA [37], and to attrition reported in the review by
Tsai & Wadden [2006]. In DiOGenes, most subjects who
did not complete the LCD period withdrew during the first
half of the LCD period. No severe adverse effects were re-
ported and participants were excluded if they reported non-
Table 1: Distribution of gender, participant age and LCD duration in the DiOGenes participating cities (n 773), 2006–2007.
Gender
Males Females
Age (y) LCD duration (weeks)
n % Pa Mean (SD) Pb Mean (SD) Pb
Maastricht 125 39.2 60.8 43.8 (5.9) 8.2 (1.4)
Copenhagen 128 40.6 59.4 43.5 (5.4) 8.3 (1.4)
Cambridge 81 25.9 74.1 43.9 (7.2) 8.0 (1.2)
Heraklion 79 36.7 63.3 40.1 (5.8) 9.0 (1.2)
Potsdam 87 39.1 60.9 42.6 (6.1) 8.7 (1.1)
Pamplona 75 45.3 54.7 44.3 (5.6) 7.8 (1.5)
Sofia 90 28.9 71.1 44.0 (7.5) 7.9 (0.9)






Total 773 35.3 64.7 43.1 (6.3) 8.2 (1.3)
LCD = low-calorie diet; SD = standard deviation; a the distribution of gender at the different centres is compared using Pearson chi-square test; b age and LCD duration at
the different centres are compared using Kruskal Wallis rank test.
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compliance with the treatment or voluntarily withdrew. It
is usual in weight loss studies that patients who do not
achieve the intended outcomes are more likely to drop out
[11] and it has recently been suggested that early weight
loss is a predictor of final weight loss during an 8-week
LCD [38]. In the present study, many of the participants
who withdrew reported that, although initially driven to
participate due to the rapid weight loss to be induced by the
LCD, they realized that this treatment method did not agree
with their lifestyle, such as outdoor eating obligations.
The marked differences in drop-out between different re-
search centres, e.g. 3% in Copenhagen and ~37% in Herak-
lion, and regions, require further investigation. However,
participants in Heraklion who completed the LCD achieved
higher percentage changes in anthropometric measure-
ments, compared to the other Southern European cities,
and the biggest changes in body composition measure-
ments among all participating cities (data not shown). One
might argue that these changes are the result of the longer
LCD period in this research centre, thus allowing more
time to achieve favourable results. However, it has been
suggested that increases in LCD duration of more than 8
weeks result in adherence difficulties and reduced compli-
ance, due to lack of dietary variation [34]. In addition, LCD
duration was taken into account in the present analyses.
As participants in Heraklion also had one of the highest
percentage body weight reductions among all participat-
ing cities (data not shown), it may be that the weight loss
achieved encouraged higher degrees of compliance among
participants not withdrawing from the LCD period early
on in the procedure. Issues of palatability/familiarity with
meal replacement products should also be considered when
attempting to clarify the present drop-out rates. For ex-
ample, soups provided in the current study were asparagus
and potato and leek soups, which are not part of the usual
Greek diet and might have discouraged some participants
from Heraklion from continuing on the LCD phase. There-
fore, future studies utilizing meal replacement products to
promote weight loss should ideally provide products with
flavours similar to local cuisines. Nevertheless, future stud-
ies should include objective measures of palatability/ac-
ceptability of LCDs, instead of relying on self-reports of
non-compliance with the treatment, in order to better un-
derstand differences in compliance, drop-out and effects
among different regions.
In the present study, no severe adverse effects of the LCD
were reported. Nonetheless, it should be noted that such
diets are not intended to substitute long-term behavioural
modification for weight loss/control. Indeed, the superior-
ity of LCDs to conventional diets has been questioned in
the past [9, 11], whereas the combined treatment of LCDs
and behavioural therapy appears to be more effective, com-
pared to LCD alone, especially with regard to long-term
weight maintenance [5, 11].
To the best of our knowledge, this is the first study to in-
vestigate the effect of LCDs on anthropometric measure-
Table 2: Mean (SD) and percental changes in anthropometric and body composition measures over the LCD period in the DiOGenes participating regions (n 773),
2006–2007.
Regions
Measurement North Central South Total
Weight (kg) Baseline 99.1 (16.0) 100.0 (16.0) 101.5 (16.0) 100.0 (16.1)
(n = 773) Mean change –11.3 (3.3) –11.1 (3.3) –10.8 (3.3) –11.1 (3.3)
% change –11.4 –11.1 –10.6 –11.1
BMI (kg/m2) Baseline 33.7 (4.9) 33.7 (4.9) 36.1 (4.8) 34.6 (5.0)
(n = 771) Mean change –3.8 (1.1) –3.7 (1.1) –3.6 (1.1) –3.8 (1.1)
% change –11.3 –11.0 –10.0 –11.0
WC (cm) b Baseline 107.4 (11.9) 105.7 (11.9) 109.8 (11.9) 107.9 (11.9)
(n = 756) Mean change –10.2 (4.7) –10.2 (4.7) –8.9 (4.7) –9.7 (4.8)
% change –9.5 –9.6 –8.1 –9.0
HC (cm) b Baseline 114.8 (10.3 116.6 (10.3) 119.3 (10.3) 117.1 (10.3)
(n = 756) Mean change –6.9 (4.1) –7.9 (4.0) –7.1 (4.0) –7.2 (3.9)
% change –6.0 –6.8 –6.0 –6.1
Waist-to-hip ratio b Baseline 0.937 (0.073) 0.908 (0.069) 0.921 (0.061) 0.923 (0.055)
(n = 756) Mean change –0.036 (0.055) –0.029 (0.042) –0.022 (0.045) –0.029 (0.055)
% change –3.8 –3.2 –2.4 –3.1
Sagittal height (cm) a Baseline 24.4 (3.6) 26.2 (3.5) 25.8 (3.5) 25.4 (3.4)
(n = 727) Mean change –3.6 (1.7) –3.4 (1.7) –2.7 (1.7) –3.2 (1.7)
% change –14.8 –13.0 –10.5 –12.6
FM (kg) b Baseline 40.9 (10.9) 37.7 (10.9) 42.4 (10.9) 40.3 (10.9)
(n = 563) Mean change –7.9 (4.4) –7.4 (4.4) –9.1 (4.4) –8.3 (4.4)
% change –19.3 –19.6 –21.5 –20.6
FFM (kg) b Baseline 59.2 (8.4) 61.6 (8.4) 60.9 (8.4) 60.1 (8.1)
(n = 563) Mean change –3.4 (4.0) –3.5 (4.0) –2.2 (4.0) –2.8 (4.0)
% change –5.7 –5.7 –3.6 –4.7
Fat percent (%) b Baseline 40.8 (5.6) 38.0 (5.6) 40.9 (5.6) 40.0 (5.5)
(n = 563) Mean change –3.9 (3.9) –3.7 (3.9) –4.8 (3.9) –4.4 (3.9)
% change –9.5 –9.7 –11.8 –11.0
LCD = low-calorie diet; SD = standard deviation; BMI = body mass index; WC = waist circumference; HC = hip circumference; FM = fat mass; FFM = fat-free mass.
Comparisons of overall mean changes between regions were performed using analysis of covariance, with age, gender and LCD duration (weeks) as covariates. a P
<0.001, b P <0.01.
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ments and body composition in such a large and diverse
sample of overweight/obese individuals. The current find-
ings might therefore prove helpful to scientists intending to
use this treatment method at a national level in the future.
However, it should be noted that our sample was not rep-
resentative of the general population in either the respect-
ive cities or countries, and thus our findings cannot be gen-
eralised. A limitation of the current study is that physical
activity levels during the LCD were not assessed. Thus,
we cannot rule out that the observed favourable changes
in obesity measures were not the combined result of the
LCD and increased physical activity. However, and also
for reasons of standardisation assurance across the research
centres, subjects were particularly requested not to change
their usual lifestyle habits, including physical activity, dur-
ing the LCD period. Nevertheless, it is noteworthy that
studies specifically designed to examine the effect of phys-
ical exercise revealed no additional weight loss when phys-
ical exercise was added to the LCD treatment [39]. In ad-
dition, our database did not provide information on more
specific acceptability measures, such as satiety produced
by the diet or the taste of the LCD products. Such meas-
urements should, if possible, be assessed during treatment
to provide an additional estimate of product acceptability
and explain potential drop-out differences. Furthermore,
the LCD in this study was not compared to any other
treatment, so recommendations regarding its efficacy might
seem inappropriate. Nevertheless, this study provides addi-
tional evidence on the effect of LCDs in a free-living situ-
ation and shows this treatment’s potential for use in differ-
ent regions.
In conclusion, the LCD significantly improved anthropo-
metric and body composition measurements in participants
in all cities participating in the DiOGenes study. Future
studies should examine objective acceptability measures of
this treatment in order to further explain regional differen-
ces in the effect of this diet on obesity.
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Figures (large format)
Figure 1
Flow diagram showing progress of the DiOGenes participants from screening to post-LCD, 2006–2007.
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Figure 2
Body fat percentage over the LCD period in the DiOGenes participating regions, 2006–2007. LCD = low-calorie diet; bars (I) indicate 95%
confidence intervals; comparisons in body fat percentage changes between regions were performed using analysis of covariance, with age,
gender, baseline body fat percentage and LCD duration (weeks) as covariates.
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